List of Studies ( Metabolite:N-Acetyl-glucosaminitol)
Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Units(range) |
---|---|---|---|---|---|---|---|
ST003084 | AN005043 | Metabolic changes in embryonic CSF (Part 6) | CSF | Mouse | Autism | Boston Children's Hospital, Harvard Medical School | a.u. |
ST003086 | AN005047 | Metabolome changes in embryonic CSF (Part 8) | CSF | Mouse | Autism | Boston Children's Hospital, Harvard Medical School | a.u. |
ST003087 | AN005048 | Metabolome changes in embryonic CSF (Part 9) | CSF | Mouse | Autism | Boston Children's Hospital, Harvard Medical School | a.u. |
ST002551 | AN004200 | Metabolomics dataset of CNTF induced axon regeneration in mice post optic nerve crush | Eye tissue | Mouse | Eye disease | University of Miami | µg/ml |
ST002111 | AN003454 | Metabolomics dataset of optogenetic axon regenerative mouse model post optic nerve crush | Eye tissue | Mouse | Eye disease | University of Miami | µg/mL |
ST002111 | AN003455 | Metabolomics dataset of optogenetic axon regenerative mouse model post optic nerve crush | Eye tissue | Mouse | Eye disease | University of Miami | µg/mL |
ST001788 | AN002900 | β-Adrenergic regulation of metabolism in macrophages (part-IV) | Macrophages | Human | Monash University | Intensity | |
ST002010 | AN003276 | Chemoresistant Ovarian Cancer Global Metabolomics | Cultured cells | Human | Cancer | The University of South Australia | Intensity |
ST002444 | AN003981 | Zebrafish Optic Nerve Regeneration Metabolomics - 3 Days Post Crush | Eye tissue | Zebrafish | Eye disease | University of Miami | normalized peak areas |
ST000259 | AN000412 | Metabolic contribution of pSymA and pSymB megaplasmid/chromid for multipartite Sinorhizobium meliloti cultured in rich LBmc medium | Cells | Sinorhizobium | McMaster University | Peak area normalized | |
ST002066 | AN003366 | Glutaminase inhibition impairs CD8 T cell activation in STK11/Lkb1 deficient lung cancer | Lung | Mouse | Cancer | The Walter and Eliza Hall Institute of Medical Research | peak height |
ST002104 | AN003439 | Chemoresistant Cancer Cell Lines are Characterized by Migratory, Amino Acid Metabolism, Protein Catabolism and IFN1 Signalling Perturbations | Cultured cells | Human | Cancer | Future Industries Institute | peak height |
ST002412 | AN003931 | Metabolic effects of the protein kinase R | Macrophages | Mouse | Hudson | peak height | |
ST002698 | AN004373 | Systemic host inflammation induces stage-specific transcriptomic modification and slower maturation in malaria parasites | Infected Red Blood Cells | Plasmodium berghei | Malaria | Peter Doherty Institute for Infection and Immunity | peak height |
ST002792 | AN004543 | Chemoproteomics validates selective targeting of Plasmodium M1 alanyl aminopeptidase as a cross-species strategy to treat malaria | Blood | Plasmodium falciparum | Malaria | Monash University | peak height |
ST003053 | AN005007 | Providing insight into the mechanism of action of Cationic Lipidated Oligomers (CLOs) using metabolomics | Bacterial cells | Staphylococcus aureus | Bacterial infection | Monash University | peak height |
ST003144 | AN005160 | On-target, dual aminopeptidase inhibition provides cross-species antimalarial activity | Blood | Plasmodium falciparum | Malaria | Monash University | peak height |
ST000403 | AN000642 | Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes | Cells | Human | Monash Institute of Pharmaceutical Sciences, Monash University | Peak height | |
ST000414 | AN000655 | Metabolomics-based screening of the Malaria Box reveals both novel and established mechanisms of action | Cells | Plasmodium falciparum | Malaria | Monash Institute of Pharmaceutical Sciences, Monash University | Peak height |
ST000539 | AN000818 | Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes (part II) | Cells | Human | Monash Institute of Pharmaceutical Sciences, Monash University | Peak height | |
ST000546 | AN000832 | Multi-omics based identification of specific biochemical changes associated with PfKelch13-mutant artemisinin resistant Plasmodium | Cells | Plasmodium falciparum | Malaria | Monash Institute of Pharmaceutical Sciences, Monash University | Peak height |
ST001033 | AN001694 | Determination of mode of action of anti-malalrial drugs using untargeted metabolomics | Cultured cells | Plasmodium falciparum | Malaria | Monash University | Peak height |
ST001274 | AN002115 | Metabolomics-based profiling of the mode of action of Pathogen Box compounds in Trypanosoma brucei (part-I) | Cultured cells | Trypanosoma brucei | Sleeping sickness | Monash University | Peak height |
ST001276 | AN002117 | Development and Characterisation of a Novel Class of Aroyl Guanidine Containing Anti-Trypanosomal Compounds | Cultured cells | Trypanosoma brucei | Sleeping sickness | Monash University | Peak height |
ST001201 | AN001998 | Peroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasites | Cultured cells | Human | Malaria | Monash University | Peak intensity |
ST001201 | AN001998 | Peroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasites | Cultured cells | Plasmodium falciparum | Malaria | Monash University | Peak intensity |
ST001202 | AN002001 | Peroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites | Cultured cells | Human | Malaria | Monash University | Peak intensity |
ST001202 | AN002001 | Peroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites | Cultured cells | Plasmodium falciparum | Malaria | Monash University | Peak intensity |
ST001204 | AN002004 | Peroxide antimalarial extended treatment timecourse on trophozoite-stage P. falciparum parasites | Cultured cells | Human | Malaria | Monash University | Peak intensity |
ST001204 | AN002004 | Peroxide antimalarial extended treatment timecourse on trophozoite-stage P. falciparum parasites | Cultured cells | Plasmodium falciparum | Malaria | Monash University | Peak intensity |
ST001205 | AN002006 | Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites | Cultured cells | Human | Malaria | Monash University | Peak intensity |
ST001205 | AN002006 | Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites | Cultured cells | Plasmodium falciparum | Malaria | Monash University | Peak intensity |
ST001547 | AN002577 | β-Adrenergic regulation of metabolism in macrophages | Macrophages | Human | Monash University | Peak intensity | |
ST002263 | AN003697 | Intermittent fasting induces rapid hepatocyte proliferation to maintain the hepatostat | Liver | Mouse | Stanford University | relative counts | |
ST002108 | AN003448 | Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 3) | Blood | Plasmodium falciparum | Malaria | Monash University | relative intensity |
ST002108 | AN003449 | Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 3) | Blood | Plasmodium falciparum | Malaria | Monash University | relative intensity |
ST001175 | AN001950 | Multi-omics analysis demonstrates unique mode of action of a potent new antimalarial compound, JPC-3210, against Plasmodium falciparum | Plasmodium cells | Plasmodium falciparum | Malaria | Monash University | Signal Intensity |
ST001304 | AN002173 | Multi-omics analysis delineates the distinct functions of sub-cellular acetyl-CoA pools in Toxoplasma gondii | Fibroblast cells | Toxoplasma gondii | Parasitic infection | Monash University | Signal Intensity |